OCGN FY 2025 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena

OCGNOcugen, Inc.

$578M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+8.8% YoY

Gross Profit

$00.0% margin

Operating Income

-$63M-1425.7% margin

Net Income

-$68M-1537.4% margin

EPS (Diluted)

$-0.23

Cash Flow

Operating Cash Flow

-$57M

Free Cash Flow

-$57M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$44M

Total Liabilities

$56M

Stockholders' Equity

-$12M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$4M	+8.8%
Gross Profit	$0	$2M	-100.0%
Operating Income	-$63M	-$55M	-14.9%
Net Income	-$68M	-$54M	-25.5%